News
02/19/2002
Press Release
Investrend Announces Investment Opinion: Isonics Analyst Coverage Initiated
by Investrend Research
Tuesday February 19, 9:06 am Eastern Time Press Release SOURCE: Investrend NEW
YORK--(BUSINESS WIRE)--Feb. 19, 2002--Analyst coverage of Isonics Corporation
(Nasdaq:ISON - news), is being initiated immediately by Investrend analyst Tom
Byrne, MBA. Reports related to the continuous coverage will be available at
Investrend's site, http://www.investrend.com/, as well as from other leading
investment portals. Isonics is a world leader in isotopically engineered materials
and produces isotopically pure silicon-28 chemicals and wafers and silicon-on-insulator
wafers (SOI) for the semiconductor industry. The company recently announced
it met its target date for shipping its SOI wafer products. Isonics also markets
and sells stable isotopes for the health care industry such as carbon-13 for
diagnostic breath tests and drug design, and oxygen-18 for positron emission
tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials.
The company's website is at http://www.isonics.com/. Tom Byrne has been an equity
analyst for 16 years, and heads Byrne Investment Research. He uses a set of
proprietary valuation techniques to understand and value companies that do not
pay dividends. Previously, Mr. Byrne was Director of Research for Individual
Investor Group, and served as a portfolio advisor for two hedge funds: WisdomTree
I and WisdomTree II. Mr. Byrne also created and served as the portfolio manager
for five Unit Investment Trusts. Additionally, he was a small cap equity analyst
at Standard & Poor's, and was an analyst with International I/B/E/S, recently
merged into First Call. Mr. Byrne has an MBA in Finance from the Fordham University
Graduate School, and is currently an adjunct professor at Monmouth University,
where he teaches courses in finance and investment analysis. Investrend Research
has been a leading independent equity research publishing and distribution program
since 1996, with more than 45 AIMR-qualified professional analysts posting more
than 360 reports to date. Anyone, including a company, investor relations practitioner,
financial institution or interested private investor, may enroll a company for
coverage. Enrollment fees vary, up to $1,850 per month for full, continuous
coverage. Analysts are paid in advance for their initial reports by Investrend
to insure independence. Full details of the company's policies and guidelines
are posted on the website at http://www.investrend.com/. Anyone interested in
receiving alerts regarding Isonics research should email info@investrend.com
with ``ISON'' in the subject line. Contact: Isonics Corporation Dr. Stephen
J. Burden, 303/279-7900 sburden@isonics.com or Investor Relations Services,
Inc. Gary Frank, 386/409-0200 ison@invrel.net or Investrend Research Div. Investrend
Communications, Inc. R. Hempel, 718/896-5060 info@investrend.com http://www.investrend.com/